Actively Recruiting

Age: 18Years +
All Genders
NCT05776342

Prognostic and Predictive Markers of Treatment Response in Patients With PAC.

Led by GERCOR - Multidisciplinary Oncology Cooperative Group · Updated on 2025-03-25

4050

Participants Needed

15

Research Sites

1513 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of this study is to identify prognosis and predictive markers of response to treatments (surgery, chemotherapy,...) in patients with pancreatic adenocarcinoma. The effectiveness and tolerance of these treatments in current practice is also evaluated.

CONDITIONS

Official Title

Prognostic and Predictive Markers of Treatment Response in Patients With PAC.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient with histologically confirmed pancreatic adenocarcinoma.
  • Disease at a resectable, borderline, locally advanced, initially metastatic, or recurrent stage after surgery.
  • Diagnosis between January 1, 2003, and December 31, 2030.
  • First-line treatment with chemotherapy and/or radiotherapy and/or clinical trials.
  • Age 65 18 years.
  • Written informed consent
Not Eligible

You will not qualify if you...

  • Patient under guardianship, curatorship, or judicial protection.
  • Pregnant or breastfeeding women.
  • Any medical, psychological, or social situation that could prevent compliance with the protocol as assessed by the investigator.
  • Refusal to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 15 locations

1

CHU Jean Minjoz

Besançon, France

Actively Recruiting

2

Hôpital Beaujon

Clichy, France

Actively Recruiting

3

CHU - Henri Mondor

Créteil, France

Not Yet Recruiting

4

CHU Lille

Lille, France

Actively Recruiting

5

Centre Léon Bérard

Lyon, France

Not Yet Recruiting

6

HRU Nancy Site Brabois

Nancy, France

Actively Recruiting

7

Hôpital Georges Pompidou

Paris, France

Actively Recruiting

8

Hôpital Saint Antoine

Paris, France

Actively Recruiting

9

Institut Mutualiste Montsouris

Paris, France

Not Yet Recruiting

10

CHU Poitiers

Poitiers, France

Not Yet Recruiting

11

CHU Reims

Reims, France

Not Yet Recruiting

12

CHU Pontchaillou

Rennes, France

Not Yet Recruiting

13

Institut Curie

Saint-Cloud, France

Not Yet Recruiting

14

IHU - Institut de chirurgie guidée par l'imagerie

Strasbourg, France

Not Yet Recruiting

15

Hôpital Paul Brousse

Villejuif, France

Actively Recruiting

Loading map...

Research Team

A

Angelique VIENOT, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Prognostic and Predictive Markers of Treatment Response in Patients With PAC. | DecenTrialz